Contract awardedVaccines and immunisation products

Bexsero MenB vaccine for UKHSA comes from GlaxoSmithKline

The UK Health Security Agency is buying Bexsero, a meningococcal group B (MenB) vaccine, from GlaxoSmithKline.

The vaccine is used in the national programme of childhood immunisation. A second, targeted programme uses it to protect adults at risk of gonorrhoea. Supply follows advice from the JCVI.

The agency announced in advance that it intended to negotiate with GlaxoSmithKline, then awarded the contract directly in May 2026. The contract can run to September 2030 with extensions. The value was withheld from publication to protect the supplier's commercial interests.

Alert me to similar tenders

Contract ends September 2029

What
Vaccines and immunisation products
Value
Not published
How it was bought
Direct award
Dates and next
Oct 2026 to Sep 2029
Being re-tendered now
Open

Being re-tendered now

Contract Notice · £1.0bn · closes 24 Sep 2028

See the live tender

How it was bought

3 official notices
  1. 9 Sep 2025Award noticeFind a Tender
  2. 22 May 2026Award noticeFind a Tender
  3. 30 Jun 2026Award noticeFind a Tender
  4. 1 Oct 2026Contract starts
  5. 24 Sep 2028Re-tender openBids dueLive tender
  6. 30 Sep 2029Contract endsUp to Sep 2030 with extension

UK Health Security Agency has bought this 12 or more times since 2021

Typical length
2 years
Suppliers used
7
in 12 of its purchases
AwardedContractWon byValue
Jun 2026Locked1 yearLocked·
Jun 2026LockedLocked·
Jun 2026Locked9 monthsLocked·
Jun 2026LockedLocked·
May 2026This purchase3 yearsGlaxoSmithKline·

and at least 7 more

Suppliers UK Health Security Agency has used in 12 of its purchases

SupplierContractsValue
GlaxoSmithKline Won this one3·
Locked2·
Locked2·
Locked2·
Locked2·

and 2 more

See the contracts and who won them

Figures to 21 November 2026

How it compares

With every vaccines and immunisation products award since 2021

Half of awards fall between £1.1m and £11mMedian £5.1m

Awards
125
Firms that won them
18
Median award
£5.1m
of 44 with a value
Typical length
2 years
In London
52 awards

GlaxoSmithKline ranks 4th of 18 firms for vaccines and immunisation products awards since 2021.

RankFirmAwardsValue
1Locked40£181.6m
2Locked19£271.8m
3Locked18·
4GlaxoSmithKline Won this one15£1.71m
5Locked13£348,613
6Locked8£20,000
See who wins this work

Vaccines and immunisation products at other buyers

UK Health Security Agency has awarded 2,546 contracts since 2021.

See UK Health Security Agency's page
  • GlaxoSmithKline has won 30 public contracts since 2021, 8 or more of them from UK Health Security Agency.

    • May 2026This purchase
    • Mar 2026Locked
    • Aug 2025Locked
    • Aug 2025Locked
    • Mar 2025Locked
    • Mar 2025Locked
    • Jul 2024Locked
    • Jul 2024Locked
    See the contracts